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a b s t r a c t
Hydrogel-based bioadhesives have emerged as alternatives for sutureless wound closure, since they can
mimic the composition and physicochemical properties of the extracellular matrix. However, they are
often associated with poor mechanical properties, low adhesion to native tissues, and lack of antimi-
crobial properties. Herein, a new sprayable, elastic, and biocompatible composite hydrogel, with broad-
spectrum antimicrobial activity, for the treatment of chronic wounds is reported. The composite
hydrogels were engineered using two ECM-derived biopolymers, gelatin methacryloyl (GelMA) and
methacryloyl-substituted recombinant human tropoelastin (MeTro). MeTro/GelMA composite hydrogel
adhesives were formed via visible light-induced crosslinking. Additionally, the antimicrobial peptide
Tet213 was conjugated to the hydrogels, instilling antimicrobial activity against Gram (þ) and (") bac-
teria. The physical properties (e.g. porosity, degradability, swellability, mechanical, and adhesive prop-
erties) of the engineered hydrogel could be ﬁne-tuned by varying the ratio of MeTro/GelMA and the ﬁnal
polymer concentration. The hydrogels supported in vitro mammalian cellular growth in both two-
dimensional and three dimensional cultures. The subcutaneous implantation of the hydrogels in rats
conﬁrmed their biocompatibility and biodegradation in vivo. The engineered MeTro/GelMA-Tet213
hydrogels can be used for sutureless wound closure strategies to prevent infection and promote heal-
ing of chronic wounds.
© 2017 Elsevier Ltd. All rights reserved.
1. Introduction
More than 2% of the US population suffers from chronic non-
healing wounds, which represent an estimated 20 billion dollars
in health care related costs each year [1]. Chronic wounds are
characterized by delayed healing and sustained inﬂammation, as
well as impaired extracellular matrix (ECM) function [2]. These
wounds can be caused by a number of pathologies including
diabetes mellitus, vascular insufﬁciency, local-pressure effects,
compromised nutritional and immunological states, surgeries, and
burns [3]. Conventional therapies for chronic wound management,
such as skin substitutes or autologous skin grafts often fail to
restore tissue homeostasis, and can lead to further health compli-
cations [3,4]. In particular, microbial infection at the wound site can
severely prolong the healing process, lead to necrosis, sepsis, and
even death [5]. Chronic wounds are highly susceptible to coloni-
zation by pathogenic bacteria such as Escherichia coli, Pseudomonas
aeruginosa, Staphylococcus aureus, Staphylococcus epidermis, various
ﬁlamentous fungi and yeasts (i.e. Candida spp.) [6e8]. Topical and
systemic antibiotic administration is frequently prescribed to pa-
tients suffering from chronic wounds. However, the over-
* Corresponding author. Department of Chemical Engineering, Northeastern
University, Boston, MA 02115, USA.
E-mail address: n.annabi@neu.edu (N. Annabi).
1 These authors contributed equally
Contents lists available at ScienceDirect
Biomaterials
journal homepage: www.elsevier .com/locate/biomater ia ls
http://dx.doi.org/10.1016/j.biomaterials.2017.05.011
0142-9612/© 2017 Elsevier Ltd. All rights reserved.
Biomaterials 139 (2017) 229e243
prescription, abuse, and misapplication of antibiotics have led to an
escalating drug resistance in pathogenic microorganisms, which is
associated with increased morbidity and mortality [9].
Polymeric hydrogels hold remarkable potential to be used as
dressings for the treatment of non-healing wounds [5,6]. Hydrogels
are hydrated three-dimensional (3D) networks of natural or syn-
thetic polymers, which can be tailored to mimic the physico-
chemical properties of human tissues. Natural polymers that are
derived from native ECM proteins such as collagen or elastin, are
particularly advantageous for tissue-engineered wound dressings
because of their inherent biocompatibility and biodegradability
both in vitro and in vivo [10]. Hydrogel-based dressings also absorb
wound exudates, which in turn promotes ﬁbroblast proliferation,
keratinocyte migration, and the eventual re-epithelialization of the
wound [11]. Furthermore, wound healing and infection prevention
can be promoted by delivering biomacromolecules, growth factors,
and other small molecule agents via polymeric scaffolds [5,6]. In
particular, previous works have demonstrated the incorporation of
antimicrobial properties to hydrogel-based dressings through
integration of different types of biocidal agents, including metal
nanoparticles [12,13], cationic polymers [14], and antimicrobial
peptides (AMPs) [15].
Despite many biological advantages of hydrogel-based dress-
ings, they often exhibit weak mechanical and adhesive properties
on thewound area, when compared to conventional wound closure
approaches (i.e. cyanoacrylate-based adhesives) [16]. Cyanoacry-
lates and aldehyde-based adhesives have been largely associated
with tissue inﬂammation, cell necrosis, and cytotoxicity [17,18].
Hydrogel-based adhesives and biologically derived ﬁbrin glues
have been shown to exhibit poor adhesion to wet tissues, and are
not able to support tissue regeneration [19]. In addition, poor me-
chanical properties and prolonged curing times of existing adhe-
sives often lead to impaired performance and tissue bonding
[20,21]. An ideal tissue adhesive for wound closure and treatment
should be (i) biocompatible and biodegradable, (ii) rapidly cross-
linked and easily applicable, (ii) antimicrobial and impervious to
antibiotic resistance, (iii) strongly adhesive, (iv) tunable and long
lasting, and (v) a promotor of tissue regeneration and wound
healing [22,23]. Therefore, new biomaterial-based approaches are
needed to address the limitations of currently available
alternatives.
Here, we present a new composite class of elastic and antimi-
crobial hydrogels, for the clinical management of chronic non-
healing wounds. The engineered hydrogels are comprised of two
biopolymers derived from native ECM proteins, gelatin and tro-
poelastin. Both gelatin methacryloyl (GelMA) [24,25] and meth-
acryloyl-substituted recombinant human tropoelastin (MeTro)
[26,27] have been previously explored to engineer hydrogels
through photocrosslinking using ultraviolet (UV) light. Although
UV light has been extensively used for photocrosslinking of
different biopolymers, it is also associated with DNA and tissue
damage [28e31], adverse effects on cell metabolic activity [32], and
suppression of the immune system in vivo [33]. Here, we describe
for the ﬁrst time the engineering of composite MeTro/GelMA
hydrogels through visible light-mediated photocrosslinking. The
use of a visible light-activated photoinitiator system eliminates the
biosafety concerns associated with UV light, while yielding me-
chanical properties similar to, or comparatively better than UV-
crosslinked hydrogels [34]. The physical, mechanical, and adhe-
sive properties of the engineered MeTro/GelMA hydrogel adhesives
were characterized. Additionally, to provide antimicrobial proper-
ties to the composite hydrogels, AMP Tet213 (KRWWKWWRRC)
[35] was conjugated to the polymeric network. The antimicrobial
properties of AMP incorporated MeTro/GelMA (MeTro/-AMP)
hydrogels were evaluated against Gram-positive (Gþ) methicillin
resistant Staphylococcus aureus (MRSA), and Gram-negative (G-)
E. coli. Lastly, in vitro and in vivo cytocompatibility of optimized
MeTro/GelMA-AMP hydrogels were investigated. The highly
tunable mechanical and adhesive properties of MeTro/GelMA-AMP
hydrogels showcase their potential for the engineering of multi-
functional, biomaterial-based therapies for the treatment of
chronic non-healing wounds.
2. Results and discussion
2.1. Synthesis and structural characterization of MeTro/GelMA
hydrogels
In this study, we present a new composite class of elastic and
antimicrobial hydrogels for the treatment of non-healing wounds.
The engineered hydrogels were synthesized using MeTro and
GelMA biopolymers, which mimic the native composition of the
ECM. MeTro is a photocrosslinkable bioelastomer comprised of
recombinant human tropoelastin, a highly elastic protein that
provides structural integrity and modulates cell function in human
tissues (Fig. 1a) [27]. On the other hand, GelMA is a photo-
crosslinkable biopolymer comprised of a modiﬁed form of dena-
tured collagen, providing physiological cell binding motifs and
protease-sensitive degradation sites (Fig. 1b) [36]. Due to their
biocompatibility and high tunable mechanical properties, UV
crosslinkable MeTro and GelMA biopolymers have been explored
for various tissue engineering applications [24,26,27]. Here, we
incorporated both MeTro and GelMA into a single polymeric
network, enabling the modulation of several features of the
resulting composite hydrogels such as degradation rate, mechani-
cal properties, porosity, and tissue adhesion. In addition, we used a
visible light activated photoinitiator system to minimize the
biosafety concerns associated with UV light. Photopolymerizable
scaffolds used for tissue engineering applications are generally
crosslinked in situ using UV light (250 nm < l < 400 nm). However,
the exposure of living cells and tissues to UV radiation can induce
DNA damage, leading to cell death and carcinogenesis [37]. To
circumvent this limitation, we investigated a method of photo-
crosslinking of MeTro and GelMA through the use of visible light
(400 nm < l < 700 nm). Visible light is cheaper, safer, and possesses
deeper tissue penetration for transdermal implantations, because
of its longer wavelength [38,39]. In addition, similar to other pho-
tocrosslinking systems, the ability to control radical formation,
makes this an ideal method for crosslinking. Visible light-induced
crosslinking of MeTro/GelMA composite hydrogels was achieved
through the incorporation of the type 2 initiator Eosin Y, with the
co-initiator triethanolamine (TEA) and the co-monomer poly(N-
vinylcaprolactam) (VC) (Fig. S1) to form an elastic and sprayable
hydrogel for wound healing (Fig. 1ced). This visible light mediated
crosslinking scheme has been thoroughly investigated, showing
improved cell viability when compared to UV crosslinked hydrogels
[40e42]. Brieﬂy, visible light excites dye molecules of Eosin Y into a
triplet state, which abstracts hydrogen atoms from TEA. The
deprotonated radicals initiate vinyl-bond crosslinking with VC via
chain polymerization reactions, which leads to accelerated gelation
[43]. The visible light photocrosslinking systems based on this
chemistry, such as FocalSeal-L (Genyzme Biosurgery, Inc., Cam-
bridge, MA), was approved by the Food and Drug Administration
(FDA) [44].
To verify the degree of crosslinking within the hydrogels, 1H
NMR (500 MHz) spectra were taken from MeTro (Fig. 1e) and
GelMA (Fig. 1f) prepolymers, and partially dissolvedMeTro/GelMA-
AMP crosslinked hydrogels (Fig. 1g). Results demonstrated that the
methacrylated groups in the co-blended MeTro/GelMA-AMP
network are involved in the formation of the 3D hydrogel network.
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Methacrylated groups (eC]CH2) appeared as characteristic peaks
corresponding to d ¼ 5.3 ppm (peak 1) and 5.7 ppm (peak 2),
respectively (Fig. 1eeg). The extent of crosslinking was determined
by the change in the integrated areas of the peaks from the
methacrylated groups after exposure to visible light. Using this
approach, we determined that the degree of crosslinking was
87.1 ± 3.9%.
2.2. Mechanical properties of MeTro/GelMA hydrogels
Mechanical properties of MeTro/GelMA composite hydrogels
were characterized through tensile and cyclic compression tests.
Tensile tests on MeTro/GelMA hydrogels revealed that the elastic
moduli (Fig. 2a) and extensibility (Fig. 2c) of the engineered
hydrogels could be modulated by varying the MeTro/GelMA ratio
and the total polymer concentration. Representative strain/stress
curves for tensile and compression tests are shown in Fig. S2. The
elastic moduli of composite hydrogels increased consistently from
4.05 ± 0.05 kPa to 18.35 ± 1.95 kPa (15% (w/v)), and from
10.25 ± 2.45 kPa to 32.2 ± 7.3 kPa (20% (w/v)) by changing the ratio
of MeTro/GelMA from 100/0 to 0/100 (Fig. 2a). Although the elastic
moduli of the engineered composite hydrogels were lower than
Fig. 1. Synthesis and 1H NMR analysis of MeTro/GelMA-AMP composite hydrogels. Design and photocrosslinking of composite hydrogels. The panel shows a schematic of the
proposed reaction for synthesis of (a) MeTro, and (b) GelMA, and (ced) MeTro-GelMA-AMP; AMP, GelMA, and MeTro were added in a TEA (co-initiator) and VC (co-initiator)
solution. Immediately prior to photocrosslinking, Eosin Y (photoinitiator) was introduced into the solution. The solution could be sprayed onto a wound area and exposed to visible
light to form an adhesive and elastic antimicrobial hydrogel layer. 1H NMR (500 MHz; D2O) spectra of (e) MeTro prepolymer, (f) GelMA prepolymer, and (g) MeTro/GelMA-AMP
hydrogels.
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that of native skin or epidermis (88 kPa - 300 kPa) [45], their
elasticity was in the range of 11.7 ± 0.6% - 70.3 ± 6.6% which is close
to the extensibility of the native skin (60e75%) [46]. It is expected
that due to the excellent biological properties of the engineered
hydrogels, cells from the surrounding tissues can inﬁltrate inside
the gel and deposit autologous ECM components to form tissues
with enhanced mechanical strength. The increased stiffness of the
hydrogels at 20% polymer concentration is likely a result of the
higher degree of crosslinking within the polymer network. Our
results showed that hydrogels with a lower MeTro concentration
exhibited a comparatively lower extensibility. This is likely due to
the increased elasticity and enhanced recoverability of MeTro
hydrogels [27]. Composite hydrogels synthesized with a 70/30
MeTro/GelMA ratio at 15% (w/v) polymer concentration, exhibited
the highest extensibility (Fig. 2c). We hypothesize that at low
concentrations, GelMA provides mechanical support to the back-
bone by its dispersion in the MeTro network. Steric hindrance
caused by GelMA elongates the entire matrix, and changes the
mechanical properties of the hydrogel by inhibiting certain MeTro
crosslink sites [47]. For instance, it has been shown that GelMA at a
low concentration (2% w/v) added to calcium phosphate cements
(CPC), greatly enhances the physical properties of the entire com-
posite, as compared to pure CPC or pure GelMA [48]. Hydrogels
synthesized with 20% (w/v) polymer concentrations yielded a
consistently higher ultimate stress as compared to lower concen-
tration (15% (w/v)), except for 70/30 MeTro/GelMA hydrogels,
where ultimate stress did not change signiﬁcantly when increasing
ﬁnal polymer concentration (Fig. 2e). Compressive tests revealed
similar tunability and control of compressive modulus (Fig. 2b)
with minimal energy loss (Fig. 2d).
Lastly, we aimed to determine if incorporation of AMP could
alter the mechanical properties of the composite scaffolds. Our
ﬁndings demonstrated that the addition of AMP resulted in no
signiﬁcant changes in both elastic and compressive moduli, in 70/
30 MeTro/GelMA hydrogels (Fig. 2f). These observations are likely
due to the fact that the small size of AMP does not signiﬁcantly alter
Fig. 2. Mechanical characterization of MeTro/GelMA and MeTro/GelMA-AMP composite hydrogels. (a) Elastic modulus, (b) compressive modulus, (c) extensibility, (d) energy
loss, and (e) ultimate stress of hydrogels produced by using 15% and 20% (w/v) total polymer concentration, at varying ratios of MeTro to GelMA. (f) Elastic and compressive modulus
of MeTro/GelMA and MeTro/GelMA-AMP (containing 0.1% (w/v) AMP) hydrogels produced by using 15% (w/v) total polymer concentration; the results show no signiﬁcant dif-
ference in mechanical properties of hydrogels with and without AMP. Data is represented as mean ± SD (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 and n $ 5).
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the microarchitecture of the polymeric 3D network [49]. Taken
together, these results demonstrated that MeTro/GelMA-AMP
hydrogels could be tuned to possess high elasticity and low fa-
tigue during continuous deformation, which is critical for hydrogel
bioadhesives used for skin tissue regeneration.
2.3. Porosity, swellability and in vitro degradation of MeTro/GelMA
hydrogels
Previous studies have investigated the inﬂuence of microstruc-
tural features of hydrogel scaffolds on the regeneration and repair of
target tissues [50]. Here, we aimed to characterize the average pore
size of MeTro/GelMA hydrogels, as well as their in vitro degradation
and swellability. Scanning electron microscopy (SEM) images were
acquired from lyophilized MeTro/GelMA hydrogels fabricated by
using different ratios of MeTro to GelMA, at both 15% (w/v) (Fig. 3a)
and 20% (w/v) (Fig. S3) polymer concentrations. Similar to the results
of mechanical testing, the pore characteristics of the composite
hydrogels were shown to be dependent on the MeTro/GelMA ratio
and the ﬁnal polymer concentration (Fig. 3b). Our results showed
that the average pore sizes of the composite hydrogels increased
from 26.85 ± 7.38 mm to 69.7 ± 11.23 mm at 15% (w/v) ﬁnal polymer
concentration, and from 10.9 ± 4.13 mm to 66.35 ± 13.92 mm at 20%
(w/v) ﬁnal polymer concentration by increasing the concentration of
GelMA (Fig. 3b). Hydrogels at 15% (w/v) polymer concentrationwere
shown to possess marginally larger pores, when compared to their
20% (w/v) counterparts. Although we observed some differences in
the porosity of the engineered hydrogels formed by using different
MeTro/GelMA ratios, it is important to note that the apparent
porosity of these hydrogels could be affected due to the lyophiliza-
tion prior to SEM analysis [50].
Swelling ratios of the composite hydrogels were also deter-
mined at various time points, throughout 24 h of incubation in
DPBS at 37 %C. Our results demonstrated that hydrogels at 15% (w/v)
(Fig. 3c) and 20% (w/v) (Fig. S4) polymer concentrations showed
increasingly higher swelling ratios for hydrogel composition con-
taining lower MeTro concentrations. 15% (w/v) hydrogels reached
their maximum swelling ratios after 24 h, which corresponded to
10.5 ± 7.5% for 100/0 MeTro/GelMA hydrogel, 38.7 ± 3.8% for 70/30
MeTro/GelMA hydrogel, 95.5 ± 5.3% for 50/50 MeTro/GelMA
hydrogel, 190.5 ± 10.1% for 30/70 MeTro/GelMA hydrogel, and
370 ± 16.2% for 0/100 MeTro/GelMA hydrogel (Fig. 3c). The wide
range of swelling ratios obtained for MeTro/GelMA hydrogels is
advantageous for tissue engineering applications since they could
be ﬁnely tuned based on their ﬁnal application. In addition, reduced
swellability of composite hydrogels at higher MeTro concentrations
could potentially enhance their adhesive properties in vivo. This is
mainly due to their enhanced structural stability in physiological
environments, long lasting tissue interactions, and sustained me-
chanical performance. For sutureless wound closure strategies, this
could greatly enhance wound healing by providing a highly
permeable and ﬂexible seal. This further regulates elimination of
exudates and production of ECM components that promote cellular
function and tissue regeneration [51].
Another technical advantage of hydrogels used for sutureless
wound closure is their controlled degradation in wet environments.
Therefore, we aimed to investigate the in vitro degradation of 15%
and 20% (w/v) MeTro/GelMA hydrogels in DPBS (Fig. S5) and DPBS
supplemented with 10% fetal bovine serum (FBS) (Fig. 3d, and
Fig. S5). Results demonstrated that the in vitro degradation rate of
the composite hydrogels were dependent on MeTro/GelMA ratio
and ﬁnal polymer concentration. Overall, in vitro degradability was
consistently higher at 50/50 MeTro/GelMA ratios for all conditions
tested. Hydrogels incubated in DPBS/FBS exhibited greater degrad-
ability, when compared to incubation in DPBS. In addition, the
incorporation of AMP resulted in no signiﬁcant changes on the de-
gradability of the composite hydrogels (Fig. 3e). In contrast, previous
studies have shown that the incorporation of antimicrobial agents
such as ZnO in protein-based biopolymers, could signiﬁcantly alter
the degradation rate of the resulting biomaterials [52].
2.4. Adhesive properties of MeTro/GelMA hydrogels
Conventional wound closure methods, such as sutures, me-
chanical fasteners, and staples are often associated with increased
localized stress, and tissue damage at the wound site. Thus, alter-
native strategies for sutureless wound closure could potentially
simplify surgical procedures, and improve patient care and prog-
nosis. In particular, tissue adhesives are associated with reduced
trauma and pain, improved cosmetic outcome, and localized de-
livery of biocidal agents [53]. Therefore, we aimed to characterize
the adhesive properties of MeTro/GelMA hydrogels, and compare
themwith those of commercially available tissue adhesives such as
Evicel (Ethicon, Somerville, NJ, USA) and Coseal (Baxter, Deerﬁeld,
IL, USA). Lap shear, burst pressure, and wound closure tests were
performed using standardized testing methodologies from the
American Society for Testing and Materials (ASTM) [16,54,55].
Lap shear strength of composite hydrogels synthesized with
different MeTro/GelMA ratios was calculated according to ASTM
F2255-05 standard [54]. Shear adhesive strength of MeTro/GelMA
hydrogels increased from 541.86 ± 69.9 kPa (100/0 MeTro/GelMA)
to 1084.85 ± 104.64 kPa (0/100 MeTro/GelMA) at 15% (w/v) ﬁnal
polymer concentration, by increasing the concentration of GelMA
(Fig. 4a). Our results also showed that increasing polymer con-
centration from 15% to 20% (w/v) signiﬁcantly enhanced the ad-
hesive properties of the resulting hydrogels. For example, the shear
strength of 70/30 MeTro/GelMA hydrogels increased from
606.34 ± 96.2 kPa at 15% (w/v) to 803 ± 101 kPa at 20% (w/v) ﬁnal
polymer concentration (Fig. 4b). These values were signiﬁcantly
higher than those observed for both Evicel (207.65 ± 67.3 kPa) and
Coseal (69.7 ± 20.6 kPa). As shown in Fig. 4b, the incorporation of
AMP had no signiﬁcant effect on the shear strength of 70/30MeTro/
GelMA produced at 15% polymer concentration.
Biomaterial-based dressings for non-healing wounds should
also be able towithstand the pressure exerted by underlying tissues
and ﬂuids from within the wound site [56]. Therefore, burst pres-
sure tests on the engineered composite hydrogels were conducted,
based on a variation of the ASTM F2392-04 standard testing for
surgical sealants [16,57]. The burst pressure for hydrogels at 15%
(w/v) polymer concentration was ranged between 2.41 ± 1.3 kPa
and 10.94 ± 2.84 kPa by changing MeTro/GelMA ratios (Fig. 4c). In
addition, the burst pressure of 70/30 MeTro/GelMA hydrogels was
also increased from 4.53 ± 1.32 kPa at 15% (w/v) to
6.84 ± 1.38 kPa at 20% (w/v) ﬁnal polymer concentration. These
values were also signiﬁcantly higher than both Evicel
(1.94 ± 0.99 kPa), and Coseal (1.68 ± 0.11 kPa), and very similar to
70/30 MeTro/GelMA hydrogels containing AMP (Fig. 4d).
Lastly, to characterize the ability of MeTro/GelMA hydrogels to
seal wound boundaries upon tensile stress, we performed in vitro
wound closure tests on native tissue, i.e. porcine skin, using ASTM
F2458-05 standard [58]. The adhesion strength obtained for
hydrogels at 15% (w/v) polymer concentration increased from
42.07 ± 2.6 kPa to 57.26 ± 5.68 kPa, by increasing the concentration
of GelMA (Fig. 4e). The adhesive strength of 70/30 MeTro/GelMA
hydrogels at 15% (w/v) (45.76 ± 2.64 kPa) and 20% (w/v)
(46.24 ± 3.88 kPa) polymer concentration, was greater than those
observed for Evicel (26.33 ± 4.67 kPa), and Coseal
(19.38 ± 17.31 kPa) (Fig. 4f). Concurrently, the addition of AMP had
no signiﬁcant effect on the adhesive strength of 70/30 MeTro/
GelMA produced at 15% polymer concentration.
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These results together demonstrated tunable adhesive proper-
ties of MeTro/GelMA hydrogels and the applicability to different
physiological scenarios. The engineered composite hydrogel ad-
hesives offer several technical advantages over commercially
available approaches, including their highly tunable nature, supe-
rior adhesive strength to native tissue, and increased resilience to
burst pressure for adequate wound closure. In addition, the ability
of GelMA to be enzymatically degraded could potentially foster
tissue remodeling, while the elasticity of MeTro could provide
mechanical support to the wound site. The strong adhesion prop-
erties of the engineered composite hydrogel can be attributed to
hydrogel-tissue interlocking [59], covalent bonding with radicals
generated during crosslinking [60], and hydrogen bonding in the
presence of free hydroxyl groups within the hydrogel matrix [61].
2.5. In vitro antimicrobial properties of MeTro/GelMA-AMP
hydrogels
In recent years, signiﬁcant efforts have been made to develop
macromolecular antimicrobial agents that are impervious to
antibiotic resistance, and can be used in the context of chronic
wound treatment [62]. AMPs are comprised of short sequences of
cationic amino acids, which have been shown to possess broad-
spectrum bactericidal activity against G(þ/") bacteria [63]. AMPs
bind to the negatively charged outer leaﬂet of bacterial cell mem-
branes, which leads to changes in bacterial surface electrostatics,
actuation upon cytoplasmic targets, increased membrane per-
meabilization, and ultimately, cell lysis [6,64]. Here, we aimed to
provide antimicrobial capabilities to the engineered MeTro/GelMA
hydrogels through the incorporation of a broad spectrum AMP. We
ﬁrst investigated the kinetics of peptide release from MeTro/
GelMA-AMP hydrogels. For this, 70/30 MeTro/GelMA hydrogels
mixed with 0.1% (w/v) AMP were incubated in DPBS at 37 %C; and
the amount of AMP released from the composite hydrogels was
determined at 280 nm absorbance. MeTro/GelMA hydrogels were
used as controls. Our results demonstrated that a burst release
(~60%) of AMP from MeTro/GelMA hydrogels took place within the
ﬁrst 8 h post-incubation (Fig. 5a). After this, a relatively steady and
sustained release of AMP (~80%) was observed for 72 h incubation.
In contrast, previous studies have reported comparatively slower
Fig. 3. Pore characteristics, swelling ratios and in vitro degradation properties of MeTro/GelMA composite hydrogels. (a) Representative SEM images and (b) pore size
characterization of MeTro/GelMA composite hydrogels at varying MeTro/GelMA ratios and 15% ﬁnal polymer concentration (scale bar ¼ 100 mm). (c) Swelling ratios (in DPBS) and
(d) degradation properties (in DPBSþ10% FBS solution) of 15% composite hydrogels at varying ratios of MeTro/GelMA at 37 %C. (e) In vitro degradation of MeTro/GelMA and MeTro/
GelMA-AMP (containing 0.1% (w/v) AMP) hydrogels at 15% (w/v) total polymer concentration and 70/30 MeTro/GelMA ratio; the results show no signiﬁcant difference in
degradation properties of hydrogels with and without AMP. Data is represented as mean ± SD (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 and n $ 5).
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burst releases of AMPs from Carbopol® (35%) [65], and alginate
sulfate (20%) [66] hydrogels at 48 h.
One possible reason for the initial burst release of AMP from the
hydrogel network could be due to AMP diffusing out of the super-
ﬁcial layer of the hydrogel network, followed by a sustained release
of AMP due to hydrogel swelling and degradation. This acute initial
release of AMP from MeTro/GelMA-AMP hydrogels could poten-
tially be advantageous in cases where colonization by pathogenic
bacteria has already occurred. Furthermore, it is important to
mention that the kinetics of the release should also be further
investigated in vivo where the hydrogel is exposed to a physiolog-
ical environment, instead of submerged in a solution. The modu-
lation of the release proﬁle of MeTro/GelMA-AMP hydrogels
through variations in the degree of crosslinking, biopolymer ratios,
or concentrations could also be explored.
The antimicrobial activity of MeTro/GelMA-AMP hydrogels was
evaluated using standard colony-forming unit (CFU) (Fig. 5bec) and
live/dead assays (Fig. 5d). We selected two model microorganisms
that are associated with microbial colonization of chronic non-
healing wounds, MRSA and E. coli. Composite hydrogels contain-
ing 0.1, 0.3% (w/v) AMP, or 3% (w/v) ZnO (control) were compared to
hydrogels without ZnO and AMP. Hydrogels were incubated for
24 h in 1 mL of tryptic soy broth containing 106 CFU/ml of either
MRSA or E. coli. After incubation, the hydrogels were harvested and
processed for CFU and live/dead assays.
First, we used a CFU assay to evaluate the ability of the MeTro/
GelMA-AMP hydrogels to prevent bacterial colonization. Hydro-
gels were washed three times with PBS and thoroughly vortexed to
release bacteria from the scaffolds. Then, the resulting bacterial
suspension was further diluted and used to seed tryptic soy agar
plates. After 24 h of incubation, the number of colonies formed on
each agar plate was counted. CFU assays demonstrated that MeTro/
Fig. 4. In vitro adhesion properties of MeTro/GelMA composite hydrogels. The in vitro shear strength of (a) composite hydrogels at varying MeTro/GelMA ratios and 15% polymer
concentration, and (b) 70/30 MeTro/GelMA hydrogels at 20% and 15% polymer concentrations with and without AMP and different commercially available adhesives (Evicel and
Coseal). The in vitro burst pressure of composite hydrogels at (c) varying MeTro/GelMA ratios and 15% polymer concentration, and (d) 70/30 MeTro/GelMA hydrogels at 20% and 15%
polymer concentrations with and without AMP and different commercially available adhesives (Evicel and Coseal). The in vitro adhesion strength of composite hydrogels at (e)
varying MeTro/GelMA ratios and 15% polymer concentration, and (f) 70/30 MeTro/GelMA hydrogels at 20% and 15% polymer concentrations with and without AMP and different
commercially available adhesives (Evicel and Coseal). Data is represented as mean ± SD (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, n $ 5).
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GelMA-AMP hydrogels were effectively protected from both MRSA
and E. coli colonization, as shown by the reduction in CFU values
when compared to MeTro/GelMA controls (Fig. 5bec). Further-
more, no statistical signiﬁcances were found between the hydro-
gels containing 0.1 and 0.3% (w/v) AMP, and those incorporated
with 3% (w/v) ZnO (Fig. 5bec and Fig. S6).
The antimicrobial ability of MeTro/GelMA-AMP hydrogels was
further evaluated using Live/Dead BacLight Bacterial Viability Kit
(Thermo Fisher Scientiﬁc). Hydrogels were harvested frombacterial
cultures, as described above, and stained according to instructions
from the manufacturer. Brieﬂy, the green-ﬂuorescent nucleic acid
dye permeates the cell membrane of both live and dead bacteria
cells. In contrast, the red-ﬂuorescent propidium iodide permeates
only through compromised cell membranes, while also quenching
the green ﬂuorescence in dead bacterial cells [67]. Our results
showed that both MRSA and E. coli were able to inﬁltrate and
effectively colonize on MeTro/GelMA hydrogels with no AMP, as
demonstrated by the predominantly green ﬂuorescence (Fig. 5d). In
contrast, composite hydrogels containing 0.1 and 0.3% (w/v) AMP
showed predominantly red ﬂuorescence, which is indicative of
dead bacterial cells. Similar to CFU assays, no observable differences
were found between hydrogels with 0.1 and 0.3% (w/v) AMP.
Furthermore, composite hydrogels incorporated with 3% (w/v) ZnO
also showed a majority of red-ﬂuorescent bacterial cells (Fig. 5d
and Fig. S6).
The antimicrobial activity of ZnO nanoparticles and their po-
tential applications for the development of wound healing ap-
proaches have been extensively reported in the literature [68,69].
However, recent studies have reported the adverse implications of
ZnO nanoparticles in metal homeostasis [70] and cardiac function
[71]. Interestingly, our results suggest that a qualitatively and
quantitatively similar antimicrobial activity can be achieved using a
concentration of AMP that is 30 times lower than that of ZnO
nanoparticles (i.e., 0.1% (w/v) AMP vs. 3% (w/v) ZnO). Therefore, the
use of peptide-based antimicrobial strategies provides a viable
alternative that could help circumvent the known limitations
associated with ZnO, and aid in the engineering of safer approaches
for the management of chronic wounds.
2.6. In vitro cytocompatibility of antimicrobial MeTro/GelMA
hydrogels
To determine the cytocompatibility of the engineered composite
hydrogels, we evaluated the in vitro viability, spreading, and
Fig. 5. In vitro AMP release proﬁle and antibacterial properties of Metro/GelMA-AMP hydrogels as compared to MeTro/GelMA (control) and Metro/GelMA-ZnO hydrogels. (a)
In vitro release proﬁle of AMP from 70/30 MeTro/GelMA-AMP hydrogels at 15% (w/v) total polymer concentration. Colony forming units test for MeTro/GelMA-AMP hydrogels with
different AMP content (0% as a control, 0.1% and 0.3% (w/v)) and 3% (w/v) ZnO nanoparticles seeded with (b)methicillin-resistant S aureus (MRSA) and (c) E. coli. (d) Representative
live/dead images from MRSA and E. coli seeded on MeTro/GelMA-AMP hydrogels with different AMP content (0% as a control, 0.1% and 0.3% (w/v)) and 3% (w/v) ZnO nanoparticles.
(Scale bar ¼ 200 mm). Data is represented as mean ± SD (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, n $ 3).
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metabolic activity of NIH-3T3 mouse embryonic ﬁbroblast cells,
using surface seeding (2D cultures) (Fig. S7) and 3D cell encapsu-
lation (Fig. 6). Cell viability, spreading, and metabolic activity were
determined using a commercial live/dead kit, Actin/DAPI staining,
and PrestoBlue assays, respectively. 2D cell studies revealed that
MeTro/GelMA hydrogels with 3% (w/v) ZnO resulted in lower cell
viability and spreading when compared toMeTro/GelMA hydrogels
with AMP and MeTro/GelMA hydrogels without AMP (controls)
(Fig. S7). Cell viability inMeTro/GelMA-AMP hydrogels and controls
remained >95%. The number of cells and their metabolic activity
increased consistently until day 5 post-seeding (Fig. S7). Cell
viability in hydrogels incorporated with 3% (w/v) ZnO
remained < 65%, with cultures comprised of predominantly non-
proliferating cells. Therefore, 3D cell encapsulation was carried
out using only MeTro/GelMA-AMP hydrogels and MeTro/GelMA
composites without AMP as controls.
3D encapsulation of 3T3 ﬁbroblasts was performed using com-
posite hydrogels (30/70 MeTro/GelMA ratio, 10% (w/v) ﬁnal poly-
mer concentration)with 0.1% (w/v) AMP and composite hydrogels
without AMPs as controls (Fig. 6). Cell-laden MeTro/GelMA
(Fig. 6aeb) and MeTro/GelMA-AMP (Fig. 6ced) hydrogels were
comprised of predominantly viable and proliferating cells over 5
days of culture. Similarly, Actin/DAPI staining revealed that 3T3
ﬁbroblasts could proliferate and spread throughout MeTro/GelMA
(Fig. 6eef) and MeTro/GelMA-AMP (Fig. 6geh) hydrogels.
Furthermore, cell viability in MeTro/GelMA-AMP hydrogels and
controls remained >85% (Fig. 6i), and the metabolic activity
increased consistently until day 5 post encapsulation (Fig. 6j).
Fig. 6. In vitro 3D cell encapsulation in MeTro/GelMA and MeTro/GelMA-AMP (0.1% (w/v) AMP) hydrogels using 3T3 cells. Representative live/dead images from 3T3 encap-
sulated within the (aeb)MeTro/GelMA (ced) and MeTro/GelMA-AMP hydrogels on days 1 and 5. Representative Actin/DAPI stained images for 3T3 cells encapsulated within (eef)
MeTro/GelMA (g, h) and MeTro/GelMA-AMP hydrogels on days 1 and 5 (scale bar ¼ 200 mm). (i) Quantiﬁcation of cell viability encapsulated in MeTro/GelMA and MeTro/GelMA-
AMP hydrogels after 1, 3, and 5 days of encapsulation. (j) Quantiﬁcation of metabolic activity of 3T3 cells encapsulated in MeTro/GelMA and MeTro/GelMA-AMP hydrogels after 1, 3,
and 5 days. 30/70 MeTro/GelMA hydrogels at 10% (w/v) total polymer concentration were used for 3D cell encapsulation. Data is represented as mean ± SD (*p < 0.05, **p < 0.01,
***p < 0.001 and ****p < 0.0001, n $ 3).
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These results demonstrated that MeTro/GelMA-AMP hydrogels
could support the proliferation and spreading of metabolically
active cells in vitro, in both 2D and 3D culture systems. A recent
study reported encapsulation and delivery of bonemarrow-derived
mesenchymal stem cells (BMSCs) in temperature sensitive hydro-
gels, to target the chronic inﬂammatory wound microenvironment
[72]. This encapsulation of BMSCs into the hydrogel led to the in-
hibition of pro-inﬂammatory M1 macrophages and signiﬁcantly
greater contraction of wounds in vivo. However, this acrylamide-
based hydrogel lacks the biological, antimicrobial, and highly
tunable mechanical properties of MeTro/GelMA hydrogels. There-
fore, the choice of MeTro/GelMA-AMP hydrogels could greatly
enhance the effectiveness of stem cell-based therapies for chronic
non-healing wounds.
2.7. In vivo biocompatibility and biodegradation of MeTro/GelMA
hydrogels
Lastly, we characterized the in vivo biodegradation of MeTro/
GelMA-AMP hydrogels, including their interaction with native tis-
sues via subcutaneous implantation in a murine animal model.
Composite hydrogels (30/70 MeTro/GelMA ratio, 15% (w/v) ﬁnal
polymer concentration) were implanted in subcutaneous pockets,
prepared along the dorsomedial skin of male Wistar rats. At days 4,
14, 28, and 56 post-implantation, animals were euthanized prior to
hydrogel retrieval, along with the adjacent tissues. Our results
revealed sustained biodegradation, as demonstrated by visual in-
spection (Fig. 7a) and changes in the percentage of both weight and
volume (Fig. 7b) of the explanted hydrogels. Explanted samples
were then ﬂash-frozen in an optimal cutting temperature (OCT)
compound, cryosectioned into 14-mm slices, and mounted in glass
slides for histological examination. Hematoxylin and eosin (H&E)
staining of the explanted samples revealed that biodegradation of
MeTro/GelMA-AMP hydrogels enabled ingrowth of predominantly
non-inﬂammatory cells and the almost complete replacement of
the hydrogel with autologous tissue (Fig. 7cee). These results
conﬁrmed that composite hydrogels could be efﬁciently bio-
degraded in vivo, through the enzymatic hydrolysis of the bio-
polymeric scaffold.
Cryosectioned samples were also analyzed through immuno-
histoﬂuorescent staining of leukocyte and macrophage antigens,
CD3 and CD68, respectively. Fluorescence images revealed negli-
gible leukocyte inﬁltration throughout the duration of the experi-
ment, as demonstrated by the absence of the red-ﬂuorescent CD3
antigen (Fig. 7feh). In contrast, macrophage inﬁltration was
observed at day 4 post-implantation, as demonstrated by the red-
ﬂuorescent CD68 antigen (Fig. 7i). However, this response was
not sustained after day 28 (Fig. 7jek). Therefore, this acute in-
ﬂammatory response may be associated with the surgical proced-
ure used to deliver the samples to the subcutaneous pockets, and is
not associated with the material itself.
These results showcase the high degree of biodegradation and
in vivo biocompatibility of MeTro/GelMA-AMP hydrogels. The rate
of degradation for protein-based polymeric hydrogels has been
shown to be modulated by variations in the concentrations of the
biopolymers. Therefore, it is possible to ﬁnely-tune the amount of
time that the hydrogels will remain associated with tissues to
ensure proper mechanical support and antimicrobial protection to
the wound site. Complex physiological responses could be elicited
through the biological activities of the biopolymers. For example,
previous studies have demonstrated the induction of angiogenic
responses by GelMA [73] and tropoelastin-based [74] biomaterials.
Furthermore, the incorporation of different types of immuno-
modulators, such as corticosteroids, nonsteroidal anti-
inﬂammatory drugs (NSAIDs), or small interfering RNAs (siRNAs),
could be further explored to modulate tissue responses at the
wound site [75].
3. Conclusion
In this work, we introduce a new class of multi-functional
hydrogel adhesives for the treatment of chronic non-healing
wounds. Composite hydrogels were synthesized from two natu-
rally derived biopolymers, MeTro and GelMA. The synergistic as-
sociation of two biopolymers with distinct physicochemical
properties enabled ﬁne-tuning of various properties of the com-
posite hydrogels including mechanical properties, in vitro and
in vivo degradation, swellability, and porosity. The adhesive prop-
erties of the composite hydrogels were shown to be readily tunable
to different physiological scenarios and comparatively superior to
commercially available tissue adhesives. Incorporation of an anti-
microbial peptide to the hydrogel network provided a wide-
spectrum antibacterial properties to MeTro/GelMA-AMP hydro-
gels, which was signiﬁcantly more potent than ZnO nanoparticles.
MeTro/GelMA-AMP hydrogels were shown to support the growth,
spread, and proliferation of both, 2D surface seeded and 3D
encapsulated ﬁbroblasts in vitro. Furthermore, MeTro/GelMA-AMP
hydrogels elicited minimal inﬂammatory responses, and were
shown to be efﬁciently biodegraded in vivo when implanted sub-
cutaneously in a murine animal model. Taken together, our results
demonstrate the remarkable potential of MeTro/GelMA-AMP
hydrogels for the engineering of sutureless regenerative and anti-
microbial hydrogel adhesives, which could prevent infection and
promote healing of chronic wounds.
4. Experimental section
4.1. Synthesis of MeTro/GelMA hydrogels
MeTro [27] and GelMA [36] biopolymers were synthesized as
described elsewhere. Lyophilized biopolymers were dissolved in a
solution containing TEA (1.8% w/v) and VC (1.25% w/v) in distilled
water. MeTro was diluted and kept at 4 %C prior to crosslinking to
prevent coacervation and aggregation of the biopolymer whereas
GelMA was held at room temperature. Eosin Y disodium salt
(0.5 mM) was dissolved separately in distilled water. The bio-
polymers/TEA/VC solutionwas mixed with Eosin Y, and 70 mL of the
ﬁnal solution was placed into polydimethylsiloxane (PDMS) cylin-
drical (diameter: 6 mm; height: 2.5 mm) molds for compressive
tests, or rectangular (14 & 5 & 1 mm) molds for tensile tests. The
resulting solution was photocrosslinked via exposure to visible
light (450e550 nm) for 160 s, using a LS1000 FocalSeal Xenon Light
Source (Genzyme). Composite hydrogels were synthesized using
ﬁve MeTro/GelMA ratios (i.e., 100/0, 70/30, 50/50, 30/70, and 0/
100), and 2 total polymer concentrations (i.e., 15% (w/v), and 20%
(w/v)). Prior to experimentation, hydrogels were incubated in DPBS
for 30 min to remove any unreacted Eosin Y.
MeTro/GelMA-AMP hydrogels were formed by dispersing 1 and
3 mg of AMP Tet213 (CSCScientiﬁc, Inc.) with TEA (1.8% (w/v)) and
VC (1.25% (w/v)) in 1 mL distilled water. The lyophilized bio-
polymers were dissolved in the AMP/TEA/VC solution, and the
complete hydrogel precursor solutions were then photocrosslinked
as described previously.
MeTro/GelMA-ZnO hydrogels were formed by dispersing 3% (w/
v) ZnO (US Research Nanomaterials, Inc.; 60e120 nm), 1.8% (w/v)
TEA, and 1.25% (w/v) VC in distilled water. The lyophilized bio-
polymers were dissolved in the ZnO/TEA/VC solution, and mixed
with Eosin Y. Following this, 70 mL of the complete hydrogel pre-
cursor solutions were pipetted into PDMS molds as required, and
photocrosslinked as described previously.
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4.2. 1H NMR characterization of MeTro/GelMA hydrogels
1H NMR analysis was conducted to calculate the degree of
crosslinking within the polymer network using a Varian Inova-500
NMR spectrometer. 1H NMR spectra were acquired from MeTro
(15% (w/v)) and GelMA (15% (w/v)) prepolymers dissolved in
deuterium oxide (D2O). MeTro/GelMA-AMP crosslinked hydrogels
(70/30 MeTro to GelMA ratio, 0.1% AMP, and 15% (w/v) ﬁnal
Fig. 7. In vivo biocompatibility and biodegradation of MeTro/GelMA-AMP composite hydrogel using a rat subcutaneous model. (a) Representative images of the MeTro/
GelMA-AMP hydrogels before implantation (Day 0) and on days 4, 14, 28, 56 post-implantation. (b) In vivo biodegradation of MeTro/GelMA-AMP hydrogels on days 0, 4, 14, 28
and 56 of implantation (n ¼ 4). Hematoxylin and eosin (H&E) staining of MeTro/GelMA-AMP sections (hydrogels with the surrounding tissue) after (c) 4 days, (d) 28 days, and (e) 56
days of implantation (scale bars ¼ 500 mm). (c) Fluorescent immunohistochemical analysis of subcutaneously implanted MeTro/GelMA-AMP hydrogels showing no signiﬁcant local
lymphocyte inﬁltration (CD3) at days (f) 4, (g) 28 and (h) 56 (scale bars ¼ 200 mm), and exhibiting macrophages (CD68) at (i) day 4 but not at days (j) 28 and (k) 56 (scale
bars ¼ 200 mm). Green, red and blue colors in (f-k) represent the MeTro/GelMA-AMP hydrogels, the immune cells, and the cell nuclei (DAPI) respectively. 50/50 MeTro/GelMA
hydrogels at 15% (w/v) total polymer concentration were used for the in vivo test. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web
version of this article.)
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polymer concentration) were ﬁrst partially dissolved overnight
under agitation in deuterated dimethyl sulfoxide (DMSO-d6). 1H
NMR spectrawere then acquired from the supernatant as described
previously in the literature [76]. Peak values of d ¼ 5.3 and 5.7 ppm
were correlated to the presence of methacrylated groups. The
extent of crosslinking was calculated from the change in peak area
for the double bond groups
!
" vðC¼CÞvt
"
within the time of exposure
to visible light (120 s), using the following formula: [76]
Extent of Crosslinking ð%Þ ¼
!
PAb " PAa
PAb
"
& 100 (1)
where PAb and PAa corresponds to the peak areas before and after
exposure to visible light, respectively, and are the concentration of
bonds participating in the crosslinking process. Peak areas were
integrated with respect to phenyl conjugated peaks at
d ¼ 6.5e7.5 ppm, using ACD/Spectrus NMR analysis software.
4.3. Characterization of the mechanical properties
After photocrosslinking, hydrogels were incubated for 1 h in
DPBS. The subsequent swollen gels were measured using digital
calipers. Uniaxial tensile test and cyclic uniaxial compression test
were conducted using an Instron 5542 mechanical tester. Hydro-
gels for tensile testing were placed between two pieces of double
sided tapewithin tension grips of the instrument, and extended at a
rate of 1 mm/min until failure. Elastic moduli were calculated by
obtaining the slope of the stress-strain curves. Hydrogels for
compressive testing were loaded onto compression plates of the
instrument under wet conditions, by submerging the plates in a
DPBS bath. Cyclic uniaxial compression tests were conducted at a
90% strain level and 1 mm/min strain rate. Hydrogels were condi-
tioned cyclically (loading and unloading) for 7 cycles. Post-
preconditioning, the hydrogel underwent a ﬁnal cycle. Compres-
sive strain (mm) and load (N) were then measured at the 8th cycle
using an Instron's Bluehill 3 software. Moduli were determined by
obtaining the tangent of the slope of the linear region on the
loading stress/strain curve. Energy loss was calculated by obtaining
the area between the loading and unloading curves (n ¼ 5).
4.4. In vitro lap shear test
Shear strength of the composite hydrogels, as well as other
commercial tissue adhesives, such as Evicel and Coseal was tested
according to the modiﬁed ASTM F2255-05 standard for tissue ad-
hesives [54]. Two pieces of 2 cm & 1 cmwere cut from a glass slide.
A 1 cm & 1 cm layer of gelatin was formed onto each piece of glass
slide, and left to dry to function as a base layer. The remaining
1 cm & 1 cm uncoated area was covered by a tape, which was later
used to clamp the glass slides into the Instron machine. A 10 mL
drop of hydrogel precursor solution was crosslinked between the
two layers of gelatin coated glass slides. The two glass slides were
placed in the mechanical tester, and tensile loading was applied
with a strain rate of 10 mm/min. Shear strength was calculated at
the point of detaching (n ¼ 5).
4.5. In vitro burst pressure test
Burst pressure of composite hydrogels, Evicel, and Coseal was
calculated by using the ASTM F2392-04 standard [57]. Porcine in-
testine was obtained from a local butcher. Intestine was placed in
between two stainless steel annuli from a custom built burst-
pressure apparatus, which consists of a metallic base holder,
pressure meter, syringe pressure setup, and data collector. A pin-
sized hole puncture was made through the intestine and air was
ﬂowed using a syringe pump at 0.5 ml/s. The hole made on the
intestine was covered with a crosslinked hydrogel, prior to initi-
ating the pump and sensor. Airﬂow was terminated post hydrogel
rupture and the burst strength (pressure) was recorded (n ¼ 5).
4.6. In vitro wound closure test
Wound closure of the composite hydrogels, Evicel, and Coseal
was calculated by using the ASTM F2458-05 standard [58]. Porcine
skin was obtained from a local butcher and cut into small strips
(1 & 2 cm), with excess fat was removed. Tissues were immersed
into PBS before testing to prevent drying in the air. The tissues were
ﬁxed onto two pre-cut poly(methyl methacrylate) slides (20 mm x
60 mm) by ethyl 2-cyanoacrylate glue (Krazy glue; Westerville, OH,
USA). 6 mm spaces was kept between the slides using the porcine
skin. The tissue was then separated in the middle with a straight
edge razor to simulate the wound. 100 mL of polymer solution was
administered onto the desired adhesive area and crosslinked by
light. Maximum adhesive strength of each sample was obtained at
the point of tearing at strain rate of 1 mm/min using a mechanical
tester (n ¼ 5).
4.7. Scanning electron microscope (SEM) analysis
SEM imaging and analysis were conducted to evaluate the
porosity of the crosslinked composite hydrogels. Lyophilized
hydrogel samples were prepared using the compressive molds
described earlier. SEM images were obtained using a Hitachi S-
4800 Scanning Electron Microscope (SEM). Pore sizes of MeTro/
GelMA hydrogels were averaged from at least 3 images from 3
samples for each condition by using ImageJ software (n ¼ 5).
4.8. Evaluation of in vitro swelling ratio and degradation
Swellability of MeTro/GelMA scaffolds was determined by
incubating the composite hydrogels in DPBS at 37 %C for 24 h.
MeTro/GelMA hydrogels were prepared as described previously for
compression testing. Samples were then lyophilized, and their
dried weights were measured. Changes in mass were recorded
throughout a 24 h incubation period in DPBS. Swelling ratio was
deﬁned by the ratio of ﬁnal weight to initial dry weight.
To evaluate the degree of in vitro degradation, hydrogels were
freeze-dried, weighed, and placed in 24-well plate with 1 ml of
DPBS or DPBS þ FBS solutions at 37 %C for 2 weeks. The DPBS/FBS
solutions were refreshed every 3 days. At days 1, 7 and 14 post-
incubation the samples were freeze-dried and weighed (n ¼ 5).
4.9. Antimicrobial peptide (Tet213) release studies
In vitro peptide release proﬁle was obtained using UV/Vis
spectroscopy. Absorbance was measured at 280 nm, which corre-
sponds to an excitation wavelength of tryptophan. A series of AMP
dilutions were prepared in DPBS (2e100 mg/ml) in order to
construct the calibration curve used to determine the AMP release
kinetics. Composite hydrogels containing AMP (0.1% w/v) were
used for the release study. AMP incorporated hydrogels were pre-
pared and then incubated in microcentrifuge tubes with 1 mL DPBS
at 37 %C. After this, 500 ml of the solution was taken from each tube
at different time points (i.e., 30 min, 60 min, 120 min, 240 min,
560 min, 1 day, 2 days, and 3 days). Finally, the AMP concentration
in each sample was measured using UV/Vis spectroscopy, and the
cumulative AMP release was calculated.
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4.10. In vitro evaluation of antimicrobial activity
Hydrogels with AMP (0.1% and 0.3% w/v), and ZnO (3% w/v),
were prepared as described previously using a compressive mold.
Next, MeTro/GelMA hydrogels containing AMP or ZnO were
deposited into a 24 well plate, in separate wells, and sterilized
under UV light. Gram-positive Methicillin Resistant Staphylococcus
aureus (MRSA) and Gram-negative E. coli (ATCC 25922) were used
as models to evaluate the antimicrobial properties of the composite
hydrogels. A single colony of each strain of bacteria was mixed in
tryptic soy broth (TSB; Sigma-Aldrich; 5 mL), and incubated over-
night in a bacterial shaker incubator (200 rpm at 37 %C). The optical
density (OD) of the resulting bacterial suspension was adjusted to
an OD of 0.52 (109 CFU/ml) at a wavelength of 570 nm using a
spectrophotometer. This suspension was then serially diluted to a
density of 106 CFU/ml. Subsequently, 1 ml of the bacterial suspen-
sion was added directly to each hydrogel. The well plate was sub-
sequently incubated in a bacterial incubator at 37 %C and 5% CO2 for
24 h. After incubation, scaffolds were carefully washed 3 times with
PBS to remove excess bacteria. For CFU assays, hydrogels were
placed in 1 ml PBS in microcentrifuge tubes, which were then
vigorously vortexed at 3000 rpm for 15 min. The vortex propagates
the release of bacteria from the scaffold into the solution. Each
bacterial suspension was serially diluted in PBS over 3 logarithmic
dilutions in a 96 well plate. Three 20-mL drops of each dilutionwere
seeded on agar (which includes TSBmedia) plates, whichwere then
incubated for 24 h at 37 %C and 5% CO2. Lastly, the number of
bacterial colonies formed on each agar plate was counted, and the
dilution factor was used to calculate CFU values. For bacterial
viability assays, hydrogels incubated in bacterial tryptic soy broth
were harvested as described previously. After washing, a com-
mercial LIVE/DEAD® BacLight™ kit (ThermoFisher Scientiﬁc) was
used to determine bacterial cell viability, according to instructions
from themanufacturer. Fluorescently stained samples were imaged
via a Zeiss Axio Observer Z1 inverted microscope.
4.11. Two-dimensional (2D) surface cell seeding
NIH 3T3 cells were cultured at 37 %C and 5% CO2 in Dulbecco's
Modiﬁed Eagle Medium (DMEM) media (Gibco), supplemented
with FBS (10% v/v) and penicillin/streptomycin (1% v/v). 70/30
MeTro/GelMA hydrogels at 15% (w/v) polymer concentrations were
used for 2D cultures. Hydrogels were formed by pipetting 7 ml of
precursor solution onto 3-(trimethoxysilyl) propyl methacrylate
(TMSPMA, Sigma-Aldrich) coated glass slides separated by 100 mm
spacers. After photocrosslinking, 3T3 cells (5 & 106 cells/ml) were
seeded on the hydrogel. 2D cultures were maintained at 37 %C, 5%
CO2, and humidiﬁed atmosphere.
4.12. Three-dimensional (3D) cell encapsulation
For 3D cell encapsulation, precursor hydrogel solutions were
prepared in cell culture media containing TEA (1.8% w/v) and VC
(1.25% w/v), and gently mixed with 3T3 cells (5 & 105 cells/ml). A
single 7 ml-drop of this mixture was pipetted on a 150 mm spacer,
and covered by a TMSPMA-coated glass slide. After photo-
crosslinking, the hydrogels were washed several times with warm
media to remove the unreacted photoinitiators. The cell-laden gels
were then placed in 24 well plates and incubated at 37 %C, 5% CO2,
and humidiﬁed atmosphere.
4.13. Cell viability and proliferation assays
Cell viability was determined via a Calcein AM/ethidium
homodimer-1 live/dead kit (Invitrogen) according to instructions
from the manufacturer. The experiments were carried out on days
1, 3 and 5 post-seeding. Fluorescence images were acquired using a
Zeiss Axio Observer Z1 inverted microscope and analyzed using
ImageJ software. Percent viability was determined as the ratio of
viable cells to total number of cells. PrestoBlue cell viability kit
(Thermo Fisher Scientiﬁc) was used to evaluate metabolic activity
(MA) of cells, according to manufacturer protocol. MA was evalu-
ated on days 0, 1, 3, and 5 post-seeding. Fluorescence intensity of
the resulting solutions was recorded at 535e560 nm excitation and
590e615 nm emission.
4.14. Subcutaneous implantation
All animal experiments were reviewed and approved by Insti-
tutional Animal Care and Use Committee (ICAUC; protocol
15e1248R) at Northeastern University (Boston, MA, USA). Male
Wistar rats (200e250 g) were obtained from Charles River (Boston,
MA, USA) and housed in the local animal care facility under con-
ditions of circadian dayenight rhythm and feeding ad libitum.
Anesthesia was achieved by isoﬂurane (2.5%) inhalation, followed
by SC buprenorphine (0.02e0.05 mg/kg) administration. After
inducing anesthesia, eight 1-cm incisions were made on the pos-
terior dorsomedial skin, and small lateral subcutaneous pockets
were prepared by blunt dissection.
Composite hydrogels (30/70 MeTro/GelMA ratio, 15% (w/v) ﬁnal
polymer concentration) were formed using cylindrical compression
molds as described previously. The hydrogels were lyophilized,
weighed, measured with digital calipers, and sterilized. The dried
sterile hydrogels were then implanted in subcutaneous pockets
along the dorsomedial skin of male Wistar rats. At days 4, 14, 28,
and 56 post-implantation, animals were euthanized and the
hydrogels were retrieved along with the surrounding tissues for
histological assessment, and placed in cold DPBS. Hydrogels used
for biodegradation studies were thoroughly washed in distilled
water, and excess tissue was carefully removed under a dissection
microscope.
4.15. Histological analysis and immunoﬂuorescent staining
After explantation, samples were ﬁxed in paraformaldehyde (4%
v/v)) for 4 h, followed by overnight incubation in 30% sucrose (30%
w/v) at 4 %C. Samples were then embedded in OCT and ﬂash frozen
in liquid nitrogen. Frozen samples were sectioned using a Leica
Biosystems CM3050 S Research Cryostat. 14-mm cryosections were
obtained and mounted in positively charged slides using DPX
mountant medium (Sigma). Slides were then processed for hema-
toxylin and eosin staining (Sigma) according to instructions from
the manufacturer. Immunohistoﬂuorescent staining was per-
formed on mounted cryosections as previously reported [77]. Anti-
CD3 [SP7] (ab16669) and anti-CD68 (ab125212) (Abcam) were used
as primary antibodies, and an Alexa Fluor 594-conjugated sec-
ondary antibody (Invitrogen) was used for detection. All sections
were counterstained with DAPI (Invitrogen), and visualized on an
AxioObserver Z1 inverted microscope.
4.16. Statistical analysis
Data analysis was carried out using a 2-way ANOVA test with
GraphPad Prism 6.0 software. Error bars representmean ± standard
deviation (SD) of measurements (*p < 0.05, **p < 0.01, and
***p < 0.001).
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